https://www.selleckchem.com/
After a median follow-up period of 86 (5-107) months, 1 (2.4%) patient had local recurrences and 3 (7.3%) distant metastases. The 5-year disease-free survival was 91.7% and 5-year overall survival 89.5%. Our experience has shown significant rates of ypT0 and ypT1 associated with excellent long-term results. Performing TEM to treat T2-3N0 rectal cancer after CRT and cCR appears to be an oncologically safe and effective procedure. Our experience has shown significant rates of ypT0 and ypT1 associated with excellent long-term results. Performing TEM to treat T
पसंद करना
टिप्पणी
शेयर करना
